Back to Royal Bank of Canada Royal Bank of Canada

VRCA

4 quarters

Position history for Royal Bank of CanadaRoyal Bank of Canada's holdings in Verrica Pharmaceuticals Inc.

Yes. Royal Bank of Canada holds 764 shares of VRCA (Verrica Pharmaceuticals), worth $5,000, as of its Q2 2026 13F filing. It reduced the position by 201 shares (-20.8%) from Q1 2026. Royal Bank of Canada has held VRCA in every 13F on record since Q3 2025, 4 quarterly filings.

Current Value

$5,000

Current Shares

764

Total Value Change

$0

Total Shares Change

-445

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
764
-20.8%
$5,0000.0%$6.12
0
2026-Q1
Increased
965
+132.0%
$5,0000.0%$5.29
17
2025-Q4
Decreased
416
-65.6%
$3,0000.0%$8.31
0
2025-Q3
New
1,209
-
$5,0000.0%$4.31
23

Other major holders of VRCA: Vanguard Capital Management LLC, Mariner, LLC, Vanguard Group Inc., Two Sigma Investments, LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used